Current practice of ototoxicity management across the United Kingdom (UK)

References

• Ahmed, M., A. Mishra, K. K. Sawlani, V. Verma, R. Garg, H. P. Singh, and S. Kumar. 2016. “Clinical Predictors of Streptomycin-Vestibulotoxicity.” Indian Journal of Otolaryngology and Head & Neck Surgery 68 (3): 359–366. doi:10.1007/s12070-015-0949-x.
   PubMed Web of Science ®Google Scholar
• Aksoy, F., R. Dogan, O. Ozturan, S. B. Eren, B. Veyseller, A. Pektas, and Ö. Hüseyinbas. 2014. “Protective Effect of Trimetazidine on Amikacin-Induced Ototoxicity in Rats.” International Journal of Pediatric Otorhinolaryngology 78 (4): 663–669. doi:10.1016/j.ijporl.2014.01.031.
   PubMed Web of Science ®Google Scholar
• Al-Malky, G., S. J. Dawson, T. Sirimanna, E. Bagkeris, and R. Suri. 2015. “High-Frequency Audiometry Reveals High Prevalence of Aminoglycoside Ototoxicity in Children with Cystic Fibrosis.” Journal of Cystic Fibrosis 14 (2): 248–254. doi:10.1016/j.jcf.2014.07.009.
   PubMed Web of Science ®Google Scholar
• American Academy of Audiology (AAA) 2009. Position Statement and Clinical Practice Guidelines. [online]. Accessed 7 June 2017. http://audiology-web.s3.amazonaws.com/migrated/OtoMonGuidelines.pdf_539974c40999c1.58842217.pdf
   Google Scholar
• American Speech Language Hearing Association (ASHA) 1994. Audiologic Management of individuals receiving cochleotoxic drug therapy. [online]. Accessed 7 June 2017. Available from: http://www.asha.org/policy/GL1994-00003.htm#r88
   Google Scholar
• Bertolini, P., M. Lassalle, G. Mercier, M. A. Raquin, G. Izzi, N. Corradini, and O. Hartmann. 2004. “Platinum Compound-Related Ototoxicity in Children: Long-Term Follow-up Reveals Continuous Worsening of Hearing Loss.” Journal of Pediatric Hematology/Oncology 26 (10): 649–655. doi:10.1097/01.mph.0000141348.62532.73.
   Web of Science ®Google Scholar
• Bess, F. H., J. Dodd-Murphy, and R. A. Parker. 1998. “Children with Minimal Sensorineural Hearing Loss: Prevalence, Educational Performance, and Functional Status.” Ear and Hearing 19 (5): 339–354. doi:10.1097/00003446-199810000-00001.
   PubMed Web of Science ®Google Scholar
• Brock, P. R., S. C. Bellman, E. C. Yeomans, C. R. Pinkerton, and J. Pritchard. 1991. “Cisplatin Ototoxicity in Children: A Practical Grading System.” Medical and Pediatric Oncology 19 (4): 295–300. doi:10.1002/mpo.2950190415.
   PubMedGoogle Scholar
• Chang, K. W. 2011. “Clinically Accurate Assessment and Grading of Ototoxicity.” The Laryngoscope 121 (12): 2649–2657. doi:10.1002/lary.22376.
   PubMed Web of Science ®Google Scholar
• Chang, K. W., and N. Chinosornvatana. 2010. “Practical Grading System for Evaluating Cisplatin Ototoxicity in Children.” Journal of Clinical Oncology 28 (10): 1788–1795. doi:10.1200/JCO.2009.24.4228.
   PubMed Web of Science ®Google Scholar
• Cotanche, D. A., and C. L. Kaiser. 2010. “Hair Cell Fate Decisions in Cochlear Development and Regeneration.” Hearing Research 266 (1–2): 18–25. doi:10.1016/j.heares.2010.04.012.
   PubMed Web of Science ®Google Scholar
• Crandell, C. C., and J. J. Smaldino. 2000. “Classroom Acoustics for Children with Normal Hearing and with Hearing Impairment.” Language, Speech, and Hearing Services in Schools 31: 362–370. doi:10.1044/0161-1461.3104.362.
   PubMed Web of Science ®Google Scholar
• Crundwell, G., P. Gomersall, and D. M. Baguley. 2016. “Ototoxicity (Cochleotoxicity) Classifications: A Review.” International Journal of Audiology 55 (2): 65–74. doi:10.3109/14992027.2015.1094188.
   PubMed Web of Science ®Google Scholar
• Fausti, S. A., W. J. Helt, D. S. Phillips, J. S. Gordon, G. W. Bratt, K. M. Sugiura, and D. Noffsinger. 2003. “Early Detection of Ototoxicity Using 1/6th-Octave Steps.” Journal of the American Academy of Audiology 14 (8): 444–450.
   PubMedGoogle Scholar
• Freyer, D. R., L. Chen, M. D. Krailo, K. Knight, D. Villaluna, B. Bliss, B. H. Pollock, et al. 2017. “Effects of Sodium Thiosulfate versus Observation on Development of Cisplatin-Induced Hearing Loss in Children with Cancer (ACCL0431): A Multicentre, Randomised, Controlled, Open-Label, Phase 3 Trial.” The Lancet Oncology 18 (1): 63–74. doi:10.1016/S1470-2045(16)30625-8.
   PubMed Web of Science ®Google Scholar
• Gurney, J. G., J. M. Tersak, K. K. Ness, W. Landier, K. K. Matthay, and M. L. Schmidt. 2007. “Hearing Loss, Quality of Life, and Academic Problems in Long-Term Neuroblastoma Survivors: A Report from the Children's Oncology Group.” Pediatrics 120 (5): e1229–e1236. doi:10.1542/peds.2007-0178.
   PubMed Web of Science ®Google Scholar
• Halmagyi, G. M., H. MacDougall, I. S. Curthoys, and L. A. McGarvie. 2012. “Video Head Impulse Test Diagnoses Vestibulotoxicity.” Otolaryngology-Head and Neck Surgery 147 (2 suppl): P95–P95.
   Google Scholar
• Imamura, S., and J. Adams. 2003. “Distribution of Gentamicin in the Guinea Pig Inner Era after Local or Systemic Application.” Jaro-Journal of the Association for Research in Otolaryngology 4 (2): 176–195. doi:10.1007/s10162-002-2036-8.
   PubMed Web of Science ®Google Scholar
• Khoza-Shangase, K., and K. Jina. 2013. “Ototoxicity Monitoring in General Medical Practice: Exploring Perceptions and Practices of General Practitioners about Drug-Induced Auditory Symptoms.” Innovations in Pharmaceuticals and Pharmacotherapy 1 (3): 250–259.
   Google Scholar
• Kikic, M., and G. Al-Malky. 2014. “G93 Aminoglycoside Use and Ototoxicity Monitoring in UK CF Units.” Archives of Disease in Childhood 99 (Suppl 1): A40–A40.
   Google Scholar
• Knight, K. R. G., D. F. Kraemer, and E. A. Neuwelt. 2005. “Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Development.” Journal of Clinical Oncology 23 (34): 8588–8596. doi:10.1200/JCO.2004.00.5355.
   PubMed Web of Science ®Google Scholar
• Lautermann, J., N. Dehne, J. Schacht, and K. Jahnke. 2004. “Aminoglycoside and Cisplatin-Ototoxicity: From Basic Science to Clinics.” Laryngo-rhino-otologie 83 (05): 317–323.
   PubMedGoogle Scholar
• Matsui, J. I., M. A. Parker, B. M. Ryals, and D. A. Cotanche. 2005. “Regeneration and Replacement in the Vertebrate Inner Ear.” Drug Discovery Today 10 (19): 1307–1312. doi:10.1016/S1359-6446(05)03577-4.
   PubMed Web of Science ®Google Scholar
• McCarthy, P., and R. Roeser. 2016. Aural Education and Counselling. [online]. Accessed 7 June 2017. Available from: http://www.betterhearing.org/hearingpedia/aural-education-and-counseling.
   Google Scholar
• McFadden, B., and A. Pittman. 2008. “Effect of Minimal Hearing Loss on Children’s Ability to Multitask in Quiet and in Noise.” Language, Speech, and Hearing Services in Schools 39: 342–351. doi:10.1044/0161-1461(2008/032).
   PubMed Web of Science ®Google Scholar
• Melchionda, V., H. Wyatt, S. Capocci, R. G. Medina, A. Solamalai, S. Katiri, S. Hopkins, I. Cropley, and M. Lipman. 2013. “Amikacin Treatment for Multidrug Resistant Tuberculosis: How Much Monitoring Is Required?” European Respiratory Journal 42 (4): 1148–1150. doi:10.1183/09031936.00184312.
   PubMed Web of Science ®Google Scholar
• Mudd, P. A. 2016. Ototoxicity. [online]. Accessed 7 June 2017. Available from: http://emedicine.medscape.com/article/857679-overview#showall.
   Google Scholar
• Mulheran, M.,. P. Hyman-Taylor, K. H. V. Tan, S. Lewis, D. Stableforth, A. Knox, and A. Smyth. 2006. “Absence of Cochleotoxicity Measured by Standard and High-Frequency Pure Tone Audiometry in a Trial of Once-versus Three-Times-Daily Tobramycin in Cystic Fibrosis Patients.” Antimicrobial Agents and Chemotherapy 50 (7): 2293–2299. doi:10.1128/AAC.00995-05.
   PubMed Web of Science ®Google Scholar
• Petersen, L., and C. Rogers. 2015. “Aminoglycoside-Induced Hearing Deficits–a Review of Cochlear Ototoxicity.” South African Family Practice 57 (2): 77–82. doi:10.1080/20786190.2014.1002220.
   Web of Science ®Google Scholar
• Phillips, J. A., and S. C. Bell. 2001. “Aminoglycosides in Cystic Fibrosis: A Descriptive Study of Current Practice in Australia.” Internal Medicine Journal 31 (1): 23–26. doi:10.1046/j.1445-5994.2001.00010.x.
   PubMed Web of Science ®Google Scholar
• Raphael, Y. 2002. “Cochlear Pathology, Sensory Cell Death and Regeneration.” British Medical Bulletin 63 (1): 25–38. doi:10.1093/bmb/63.1.25.
   PubMedGoogle Scholar
• Roland, P. S. 2004. “New Developments in Our Understanding of Ototoxicity.” Ear, Nose, &Amp; Throat Journal 83 *(9 Suppl 4): 15.
   PubMedGoogle Scholar
• Ruhl, D. S., B. B. Cable, and D. W. Martell. 2014. “Medication Associated with Hearing Loss: 25 Years of Medical Malpractice Cases in the United States.” Otolaryngology-Head and Neck Surgery 151 (3): 431–437. doi:10.1177/0194599814536850.
   PubMed Web of Science ®Google Scholar
• Scheenstra, R. J., H. G. Heijerman, C. L. Zuur, D. J. Touw, and E. Rijntjes. 2010. “No Hearing Loss after Repeated Courses of Tobramycin in Cystic Fibrosis Patients.” Acta Oto-Laryngologica 130 (2): 253–258. doi:10.3109/00016480903015150.
   PubMed Web of Science ®Google Scholar
• Schell, M. J., V. A. McHaney, A. A. Green, L. E. Kun, F. A. Hayes, M. Horowitz, and W. H. Meyer. 1989. “Hearing Loss in Children and Young Adults Receiving Cisplatin with or without Prior Cranial Irradiation.” Journal of Clinical Oncology 7 (6): 754–760. doi:10.1200/JCO.1989.7.6.754.
   PubMed Web of Science ®Google Scholar
• Sha, S. H., R. Taylor, A. Forge, and J. Schacht. 2001. “Differential Vulnerability of Basal and Apical Hair Cells Is Based on Intrinsic Susceptibility to Free Radicals.” Hearing Research 155 (*1–2): 1–8. doi:10.1016/S0378-5955(01)00224-6.
   PubMed Web of Science ®Google Scholar
• Theunissen, E. A., W. A. Dreschler, M. N. Latenstein, C. R. Rasch, S. van der Baan, J. P. de Boer, A. J. Balm, and C. L. Zuur. 2014. “A New Grading System for Ototoxicity in Adults.” Annals of Otology, Rhinology & Laryngology 123 (10): 711–718. doi:10.1177/0003489414534010.
   PubMed Web of Science ®Google Scholar
• Tieu, C., and K. C. Campbell. 2013. “Current Pharmacologic Otoprotective Agents in or Approaching Clinical Trials: How They Elucidate Mechanisms of Noise-Induced Hearing Loss.” Otolaryngology 3 (1): 1–6.
   Google Scholar
• Ton, C., and C. Parng. 2005. “The Use of Zebrafish for Assessing Ototoxic and Otoprotective Agents.” Hearing Research 208 (1–2): 79–88. doi:10.1016/j.heares.2005.05.005.
   PubMed Web of Science ®Google Scholar
• van Ruijven, M. W., J. C. de Groot, S. F. Klis, and G. F. Smoorenburg. 2005. “The Cochlear Targets of Cisplatin: An Electrophysiological and Morphological Time-Sequence Study.” Hearing Research 205 (1–2): 241–248. doi:10.1016/j.heares.2005.03.023.
   PubMed Web of Science ®Google Scholar
• Verdel, B. M., E. P. van Puijenbroek, P. C. Souverein, H. G. Leufkens, and A. C. Egberts. 2008. “Drug-Related Nephrotoxic and Ototoxic Reactions.” Drug Safety 31 (10): 877–884. doi:10.2165/00002018-200831100-00006.
   PubMed Web of Science ®Google Scholar
• Walker, E. M., Jr, M. A. Fazekas-May, and W. R. Bowen. 1990. “Nephrotoxic and Ototoxic Agents.” Clinics in Laboratory Medicine 10 (2): 323–354.
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO) 1994. Report of an Informal Consultation on Strategies for Prevention of Hearing Impairment from Ototoxic Drugs. [online]. Accessed 7 August 2017. Available from: http://www.who.int/pbd/deafness/ototoxic_drugs.pdf
   Google Scholar
• World Health Organisation (WHO) 1997. Prevention of Noise-induced Hearing Loss: Report of an Informal Consultation. [online]. Accessed 7 August 2017. Available from: http://www.who.int/pbd/deafness/en/noise.pdf
   Google Scholar
• Yang, T. H., Y. H. Young, and S. H. Liu. 2011. “EGb 761 (Ginkgo Biloba) Protects Cochlear Hair Cells against Ototoxicity Induced by Gentamicin via Reducing Reactive Oxygen Species and Nitric Oxide-Related Apoptosis.” The Journal of Nutritional Biochemistry 22 (9): 886–894. doi:10.1016/j.jnutbio.2010.08.009.
   PubMed Web of Science ®Google Scholar
• Yorgason, J. G., J. N. Fayad, and F. Kalinec. 2006. “Understanding Drug Ototoxicity: Molecular Insights for Prevention and Clinical Management.” Expert Opinion on Drug Safety 5 (3): 383–399. doi:10.1517/14740338.5.3.383.
   PubMed Web of Science ®Google Scholar